Tareq Abadl: Can Vitamin C Trick a Glucose Reading?
Tareq Abadl, Medical Laboratory Specialist and Director of the Blood Bank at Dr. Abdelkader Al-Mutawakkil Hospital, shared a post on LinkedIn:
”Can Vitamin C Trick a Glucose Reading?
In clinical biochemistry and medical laboratory science, not every ‘high glucose’ result reflects a patient’s true blood sugar level.
Ascorbic acid (vitamin C) can interfere with some point-of-care glucose meters and continuous glucose monitoring (CGM) systems, leading to falsely elevated glucose readings on certain devices.
The ADA 2026 Standards of Care highlight an important point:
Clinicians should always consider medication and substance interference-including vitamin C-when interpreting glucose results.
Why does this matter?
Because a falsely high glucose value can lead to:
- Incorrect clinical interpretation
- Unnecessary or inappropriate treatment
- Potential risk to the patient
In fact, hospital evaluations have shown that 2 out of 3 glucose meters tested produced falsely elevated readings when vitamin C levels increased.
Lab Takeaway: Think Beyond the Number
When a glucose result doesn’t match the clinical picture, ask:
- Is the patient taking high-dose vitamin C or receiving IV ascorbic acid?
- Is the device known to be susceptible to interference?
- Should the result be confirmed with laboratory plasma glucose or a different method?
Guidance for CGM systems also notes that high doses of vitamin C may falsely elevate readings-confirmation is recommended when values don’t match symptoms.”
Other posts featuring Tareq Abadl on Hemostasis Today.
-
Sep 9, 2026, 17:57CRISPR/Cas Gene Editing in β-Thalassemia: From Molecular Correction to Clinical Reality
-
Sep 9, 2026, 17:38Cardiovascular Health in Bleeding Disorders – EHC
-
Sep 9, 2026, 17:33Manasvi Shah: Co-Inheritance of Alpha Globin Gene Multiplication With Beta Globin Gene Abnormalities
-
Sep 9, 2026, 17:29Christina Crossette-Thambiah: One of the Largest Studies to Date in Antiphospholipid Syndrome
-
Sep 9, 2026, 17:25Alan Nurden: A miR-146a Variant Reveals a New Pathway Linking Platelet Metabolism and Thrombosis
-
Sep 9, 2026, 17:17When Is Thrombophilia Testing Appropriate and How Can the Evidence Guide Clinical Care? – ISTH
-
Sep 9, 2026, 16:07Zahra Safarzadeh: From Novel F8 Variant to Clinical Significance
-
Sep 9, 2026, 16:00Maximo Agustin Schiavone: HDL Beyond Cholesterol – Linking Lipids and Immunity
-
Sep 9, 2026, 15:56Abdul Mannan: When Antiseizure Drugs Alter DOAC Risk